Sygnature Discovery has been identified as one of London Stock Exchange Group’s 1000 Companies to Inspire Britain.
The report is a celebration of the UK’s fastest-growing and most dynamic small and medium sized businesses across the UK. To be included in the list, companies needed to show consistent revenue growth over a minimum of three years, significantly outperforming their industry peers. More detail on the methodology can be found in the report […]
2nd May 2017 – Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has enhanced its Biophysics capability with the addition of GE Healthcare’s Biacore 8K SPR system to the Biacore T200 SPR system that the company already has in-house. As the newest member of GE Healthcare’s […]
21 April 2017 – Nottingham, UK – Sygnature Discovery has today been recognised with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise, International Trade. Today the company employs over 150 dedicated scientists who research potential new medicines to treat a host of debilitating and often fatal diseases. This […]
View All News
Meet Sygnature at the following Conferences throughout 2015:
Biotech Showcase/JP Morgan
9-11th January 2017
San Francisco USA
RSC OrgSyn 50
27-28 February 2017
Proventa Medicinal Chemistry Strategy
14th March 2017
View All Conferences
View All Media
KINASE INHIBITORS, FRICKEL, Fritz-Frieder
KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).
PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne
PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).
KINASE INHIBITORS, FYFE, Matthew Colin Thor
KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).
View All Publications
Senior Scientists in DMPK
Commercial Contracts Associate